Published in Int J Chron Obstruct Pulmon Dis on April 01, 2016
A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med (2008) 17.19
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax (2002) 8.77
Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax (2012) 4.06
COPD exacerbations .1: Epidemiology. Thorax (2006) 2.94
Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc (2008) 2.20
Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest (2009) 2.16
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2012) 1.95
Exacerbations of chronic obstructive pulmonary disease. Respir Care (2003) 1.80
Risk factors of hospitalization and readmission of patients with COPD exacerbation--systematic review. Int J Chron Obstruct Pulmon Dis (2007) 1.67
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis. Cochrane Database Syst Rev (2014) 1.56
Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD). BMJ Open (2014) 1.56
Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest (2015) 1.25
Should we view chronic obstructive pulmonary disease differently after ECLIPSE? A clinical perspective from the study team. Am J Respir Crit Care Med (2014) 1.20
COPD management costs according to the frequency of COPD exacerbations in UK primary care. Int J Chron Obstruct Pulmon Dis (2014) 1.11
Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis (2015) 1.03
Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study. BMJ Open (2014) 1.02
GOLD guidelines 2011: what are the implications for primary care? Prim Care Respir J (2012) 0.94
Impact of maintenance therapy on hospitalization and expenditures for Medicare beneficiaries with chronic obstructive pulmonary disease. Am J Geriatr Pharmacother (2010) 0.92
Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease. Pharmacoeconomics (2015) 0.89
Resource Use and Costs up to Two Years Post Diagnosis Among Newly Diagnosed COPD Patients in the UK Primary Care Setting: A Retrospective Cohort Study. COPD (2014) 0.87
COPD exacerbation frequency, pharmacotherapy and resource use: an observational study in UK primary care. COPD (2013) 0.84
Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013. Int J Chron Obstruct Pulmon Dis (2015) 0.81
Comparison of resource use by COPD patients on inhaled therapies with long-acting bronchodilators: a database study. BMC Pulm Med (2011) 0.80
A changing landscape: diagnosis and management of COPD. Br J Nurs (2015) 0.77
Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids. Allergy Asthma Immunol Res (2017) 0.81
An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma. Pragmat Obs Res (2017) 0.75